Reasons for Switching Antihypertensive Medication in General Practice A Cross-Sectional Czech Nationwide Survey

被引:6
作者
Vaclavik, Jan [1 ,2 ]
Vysocanova, Petra [3 ]
Seidlerova, Jitka [4 ]
Zajicek, Petr [5 ]
Petrak, Ondrej [6 ,7 ]
Dlask, Jaroslav [8 ]
Kryza, Jiri
机构
[1] Univ Hosp Olomouc, Dept Internal Med Cardiol 1, Olomouc 77520, Czech Republic
[2] Palacky Univ, Fac Med & Dent, CR-77147 Olomouc, Czech Republic
[3] Univ Hosp Brno, Dept Internal Cardiol Med, Brno, Czech Republic
[4] Charles Univ Prague, Fac Med Pilsen, Dept Internal Med 2, Prague, Czech Republic
[5] Valasske Mezirici Hosp, Dept Internal Med, Valasske Mezirici, Czech Republic
[6] Charles Univ Prague, Fac Med 1, Dept Med 3, Prague, Czech Republic
[7] Gen Univ Hosp, Prague, Czech Republic
[8] Boehringer Ingelheim Czech Republ, Prague, Czech Republic
关键词
BLOOD-PRESSURE CONTROL; UNCONTROLLED HYPERTENSION; UNITED-STATES; POPULATION; AMLODIPINE; COMBINATIONS; MANAGEMENT; CARE;
D O I
10.1097/MD.0000000000000168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To improve blood pressure (BP) control of their patients, physicians either adjust or switch antihypertensive medication. Currently, there is only limited information available on why physicians decide to switch antihypertensive medications. A questionnaire-based survey was performed between November 2011 and March 2012 in the Czech Republic. General practitioners were asked to fill in questionnaires about their hypertensive patients whose antihypertensive medication they were planning to change. These questionnaires recorded data about patient demographic information, cardiovascular risk factors, BP values, and reasons for switching anti-hypertensive medication. Two hundred eight-six general practitioners surveyed a total of 4341 hypertensive patients. The mean age of the patients was 59.8 years, 68.9% of patients were overweight or obese. Uncontrolled office systolic and diastolic BP >140/90 mm Hg was present in 89.6% and 81.5% of patients, respectively, despite the fact that 49.4% of patients used a combination of 2 or more antihypertensive drugs. The most common reasons for switching medication were insufficient BP control (73.7%), followed by aiming for a better 24-hour effect (38.4%) and increased cardiovascular risk of the patients (37.7%). The major reason for switching antihypertensive treatment in general practice was insufficient BP control. Switching medication because of adverse drug effects is less frequent than reported a decade ago.
引用
收藏
页数:5
相关论文
共 19 条
[1]   Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy [J].
Ambrosioni, E ;
Leonetti, G ;
Pessina, AC ;
Rappelli, A ;
Trimarco, B ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 2000, 18 (11) :1691-1699
[2]   Fixed-dose combinations improve medication compliance: A meta-analysis [J].
Bangalore, Sripal ;
Kamalakkannan, Gayathri ;
Parkar, Sanobar ;
Messerli, Franz H. .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (08) :713-719
[3]   Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial [J].
Brown, Morris J. ;
McInnes, Gordon T. ;
Papst, Cheraz Cherif ;
Zhang, Jack ;
MacDonald, Thomas M. .
LANCET, 2011, 377 (9762) :312-320
[4]   Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial [J].
Dahlöf, B ;
Sever, PS ;
Poulter, NR ;
Wedel, H ;
Beevers, DG ;
Caulfield, M ;
Collins, R ;
Kjeldsen, SE ;
Kristinsson, A ;
McInnes, GT ;
Mehlsen, J ;
Nieminen, M ;
O'Brien, E ;
Östergren, J .
LANCET, 2005, 366 (9489) :895-906
[5]   Antihypertensive medication changes and blood pressure goal achievement in a managed care population [J].
Engel-Nitz, N. M. ;
Darkow, T. ;
Lau, H. .
JOURNAL OF HUMAN HYPERTENSION, 2010, 24 (10) :659-668
[6]   Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study [J].
Grassi, Guido ;
Cifkova, Renata ;
Laurent, Stephane ;
Narkiewicz, Krzysztof ;
Redon, Joseph ;
Farsang, Csaba ;
Viigimaa, Margus ;
Erdine, Serap ;
Brambilla, Gianmaria ;
Bombelli, Michele ;
Dell'Oro, Raffaella ;
Notari, Massimo ;
Mancia, Giuseppe .
EUROPEAN HEART JOURNAL, 2011, 32 (02) :218-225
[7]  
Hu D, 2004, HEART DRUG, V1, P77
[8]   Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients [J].
Jamerson, Kenneth ;
Weber, Michael A. ;
Bakris, George L. ;
Dahlof, Bjorn ;
Pitt, Bertram ;
Shi, Victor ;
Hester, Allen ;
Gupte, Jitendra ;
Gatlin, Marjorie ;
Velazquez, Eric J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23) :2417-2428
[9]  
Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3
[10]   Predictors of uncontrolled hypertension in ambulatory patients [J].
Knight, EL ;
Bohn, RL ;
Wang, PS ;
Glynn, RJ ;
Mogun, H ;
Avorn, J .
HYPERTENSION, 2001, 38 (04) :809-814